Innovita Biological Technology Balance Sheet Health
Financial Health criteria checks 6/6
Innovita Biological Technology has a total shareholder equity of CN¥2.0B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥2.1B and CN¥128.5M respectively. Innovita Biological Technology's EBIT is CN¥328.3M making its interest coverage ratio -11.7. It has cash and short-term investments of CN¥1.8B.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | -11.7x |
| Cash | CN¥1.80b |
| Equity | CN¥1.99b |
| Total liabilities | CN¥128.53m |
| Total assets | CN¥2.12b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 688253's short term assets (CN¥1.9B) exceed its short term liabilities (CN¥121.4M).
Long Term Liabilities: 688253's short term assets (CN¥1.9B) exceed its long term liabilities (CN¥7.1M).
Debt to Equity History and Analysis
Debt Level: 688253 is debt free.
Reducing Debt: 688253 has no debt compared to 5 years ago when its debt to equity ratio was 2%.
Debt Coverage: 688253 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 688253 has no debt, therefore coverage of interest payments is not a concern.